Beta Bionics

(NASDAQ) BBNX

Current Price$9.21

Market Cap$421.55M

Since IPO (2025)-60%

5 YearN/A

1 Year-31%

1 Month-27%

Beta Bionics Financials at a Glance

Market Cap

$421.55M

Revenue (TTM)

$110.24M

Net Income (TTM)

$66.44M

EPS (TTM)

$-1.51

P/E Ratio

-6.26

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$9.21

Volume

31,944

Open

$9.43

Price

$9.21

Volume

31,944

Open

$9.43

Previous Close

$9.46

Daily Range

$9.05 - $9.65

52-Week Range

$8.80 - $32.71

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$9.21

Volume

31,944

Open

$9.43

Previous Close

$9.46

Daily Range

$9.05 - $9.65

52-Week Range

$8.80 - $32.71

BBNX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Beta Bionics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

423

CEO

Sean Thomas Saint

Website

www.betabionics.com

Headquarters

Irvine, CA 92618, US

BBNX Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-70%

Net Income Margin

-60%

Return on Equity

-23%

Return on Capital

-27%

Return on Assets

-22%

Earnings Yield

-15.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$421.55M

Shares Outstanding

44.56M

Volume

31.94K

Avg. Volume

1.10M

Financials (TTM)

Gross Profit

$55.54M

Operating Income

$71.68M

EBITDA

$73.20M

Operating Cash Flow

$50.92M

Capital Expenditure

$5.30M

Free Cash Flow

$56.22M

Cash & ST Invst.

$219.13M

Total Debt

$7.30M

Beta Bionics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$27.63M

+56.6%

Gross Profit

$16.44M

+83.2%

Gross Margin

59.50%

N/A

Market Cap

$421.55M

N/A

Market Cap/Employee

$1.20M

N/A

Employees

352

N/A

Net Income

$21.89M

+23.6%

EBITDA

$24.27M

-34.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$192.61M

-14.2%

Accounts Receivable

$17.89M

+62.4%

Inventory

$23.73M

+50.8%

Long Term Debt

$5.07M

-6.9%

Short Term Debt

$1.84M

+20.7%

Return on Assets

-21.82%

N/A

Return on Invested Capital

-27.49%

N/A

Free Cash Flow

$25.21M

-24.1%

Operating Cash Flow

$23.83M

-19.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ORICORIC Pharmaceuticals, Inc.

ORICORIC Pharmaceuticals, Inc.$7.86-3.56%

KMTSKestra Medical Technologies, Ltd.

KMTSKestra Medical Technologies, Ltd.$19.57-1.24%

PGENPrecigen, Inc.

PGENPrecigen, Inc.$4.05-8.26%

TRMLTourmaline Bio, Inc.

TRMLTourmaline Bio, Inc.$47.98+0.00%

IMTXImmatics N.V.

IMTXImmatics N.V.$10.52-3.22%

AHCOAdaptHealth Corp.

AHCOAdaptHealth Corp.$10.70+0.42%

STAASTAAR Surgical Company

STAASTAAR Surgical Company$32.29+0.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.02-0.07%

POETPoet Technologies

POETPoet Technologies$13.73-0.14%

FFord Motor Company

FFord Motor Company$13.05-0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.25-0.04%

NUNu Holdings

NUNu Holdings$12.13-0.00%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$5.24+0.18%

TET1 Energy Inc.

TET1 Energy Inc.$6.54+0.15%

Questions About BBNX

What is the current price of Beta Bionics?

Beta Bionics is trading at $9.21 per share.

What is the 52-week range for Beta Bionics?

Over the past 52 weeks, Beta Bionics has traded between $8.80 and $32.71.

How much debt does Beta Bionics have?

As of the most recent reporting period, Beta Bionics reported total debt of $6.91M.

How much cash does Beta Bionics have on hand?

Beta Bionics reported $30.31M in cash and cash equivalents in its most recent financial results.

What is Beta Bionics’s dividend yield?

Beta Bionics does not currently have a dividend yield.

Beta Bionics

Beta Bionics Financials at a Glance

BBNX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Beta Bionics

BBNX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Beta Bionics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BBNX

What is the current price of Beta Bionics?

What is the 52-week range for Beta Bionics?

How much debt does Beta Bionics have?

How much cash does Beta Bionics have on hand?

What is Beta Bionics’s dividend yield?

Premium Investing Services